(Q35997686)

11 August 2017

1 reference

title

C-reactive protein in end-stage renal disease: are there reasons to measure it? (English)

1 reference

11 August 2017

1 reference

1

Peter Stenvinkel

1 reference

11 August 2017

2

Bengt Lindholm

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

72-78

1 reference

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

11 August 2017

cites work

1 reference

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

21 January 2018

1 reference

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

C-reactive protein and coronary heart disease

21 January 2018

1 reference

Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease

21 January 2018

1 reference

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

21 January 2018

1 reference

C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis

21 January 2018

1 reference

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

Vascular smooth muscle cell activation by C-reactive protein

21 January 2018

1 reference

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence

21 January 2018

1 reference

C-reactive protein relaxes human vessels in vitro

21 January 2018

1 reference

Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone.

21 January 2018

1 reference

Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease

21 January 2018

1 reference

Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective

21 January 2018

1 reference

Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients

21 January 2018

1 reference

Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS.

21 January 2018

1 reference

White blood cells as a novel mortality predictor in haemodialysis patients

21 January 2018

1 reference

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

21 January 2018

1 reference

Septicemia in the United States dialysis population, 1991 to 1999.

21 January 2018

1 reference

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

21 January 2018

1 reference

Associations between circulating inflammatory markers and residual renal function in CRF patients

21 January 2018

1 reference

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance.

21 January 2018

1 reference

Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.

21 January 2018

1 reference

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

21 January 2018

1 reference

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

21 January 2018

1 reference

Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

21 January 2018

1 reference

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000082014

1 reference

11 August 2017

1 reference